We next compared the transcription levels of KLFs between breast cancer and normal tissues using GEPIA (Fig. 2A) and found that KLF2/4/6/8/9/11/15 were significantly downregulated in tumor tissues (Fig. 2B). This evidence concerns the gene KLF2 and breast cancer.